NOVOZYMES A/S SPONS.ADR 1 Free Cash Flow Generation Index
NOVOZYMES A/S SPONS.ADR 1 free cash flow generation index. NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Free Cash Flow Generation Index of 0.44x as of March 2026. Free cash flow of €74.00 Million represents 0% of operating cash flow (€167.10 Million). Check NOVOZYMES A/S SPONS.ADR 1 (NZM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
Free cash flow generation index of NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025. Historical FCF Generation Index trend for NOVOZYMES A/S SPONS.ADR 1 across 5 annual periods. Explore how much does NOVOZYMES A/S SPONS.ADR 1 reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
NOVOZYMES A/S SPONS.ADR 1 Free Cash Flow Generation Index by Year (2021–2025)
NOVOZYMES A/S SPONS.ADR 1 free cash flow generation index by year from 2021 to 2025. Year-by-year Free Cash Flow Generation Index for NOVOZYMES A/S SPONS.ADR 1. For the full cash flow conversion analysis, see NZM cash generation efficiency.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | €750.70 Million | €1.22 Billion | €470.80 Million | ▼ -5.0% |
| 2024 | 0.65x | €660.10 Million | €1.02 Billion | €359.80 Million | ▲ +28.2% |
| 2023 | 0.50x | €281.30 Million | €557.10 Million | €275.80 Million | ▲ +81.3% |
| 2022 | 0.28x | €149.78 Million | €537.65 Million | €387.87 Million | ▼ -59.9% |
| 2021 | 0.69x | €379.44 Million | €546.17 Million | €166.73 Million | — |